Whitehawk Therapeutics, Inc.

WHWK · Nasdaq · SIC 2834: Pharmaceutical Preparations
206
SEC Filings

Business Summary

PART I . Overview We are a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology that are intended to efficiently deliver improved cancer treatments. We have deep experience in chemistry, formulation, and drug delivery, as well as research, clinical, and commercial pharmaceutical development, resulting in successfully taking product candidates from the clinic to approval, launch, and commercialization. In December 2024, we entered into an intell...

Next Earnings

Q2 FY2026 — expected 2026-08-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionWHWKdiscussed_in_filing Cybersecurity
topic_mentionWHWKdiscussed_in_filing Cybersecurity
topic_mentionWHWKdiscussed_in_filing Healthcare & Bio
topic_mentionWHWKdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001193125-26-104158EDGAR110K words
2025-03-282024-12-310001628280-25-015269EDGAR—
2024-03-132023-12-310001628280-24-010901EDGAR—
2023-03-292022-12-310001628280-23-009583EDGAR—
2022-03-172021-12-310001564590-22-010721EDGAR—
2021-03-112020-12-310001564590-21-012252EDGAR—
2020-03-162019-12-310001564590-20-011174EDGAR—
2019-03-072018-12-310001564590-19-006602EDGAR—
2018-03-152017-12-310001564590-18-005868EDGAR—
2017-03-072016-12-310001213900-17-002066EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-268895EDGAR81K words
2025-08-072025-06-300000950170-25-105081EDGAR—
2025-05-082025-03-310001628280-25-023932EDGAR—
2024-11-062024-09-300001628280-24-045698EDGAR—
2024-08-072024-06-300001628280-24-035636EDGAR—
2024-05-082024-03-310001628280-24-021657EDGAR—
2023-11-082023-09-300001628280-23-037905EDGAR—
2023-08-092023-06-300001628280-23-028562EDGAR—
2023-05-102023-03-310001628280-23-017234EDGAR—
2022-11-092022-09-300001628280-22-029228EDGAR—
2022-08-102022-06-300001628280-22-022208EDGAR—
2022-05-122022-03-310001564590-22-019856EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-120001193125-26-103117EDGAR2K words
2025-11-060001193125-25-268134EDGAR—
2025-08-070000950170-25-104592EDGAR—
2025-06-130001193125-25-140810EDGAR—
2025-05-080001628280-25-023788EDGAR—
2025-03-260001193125-25-063253EDGAR—
2025-03-180001193125-25-056708EDGAR—
2025-03-040001193125-25-045605EDGAR—
2024-12-200001193125-24-282407EDGAR—
2024-11-060001628280-24-045465EDGAR—

206 total filings indexed. 174 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001422142
TickerWHWK
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ef33a04626b9448cee9224994f9e7eef63d8a0df6f7703cdba535cc6f323f28e
parent: c1c6f8bc5a8411d268093f4adedf60999bb755ba82a5f9941996aba6efbb6a2b
content hash: de6b80d57ac0ca8119fd5e566736da3e734fa24d5d49181db583e28218a22479
signed: 2026-04-13T04:48:13.312Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf